Related Experiment Videos
[Butyrylcholinesterase: 3D structure, catalytic mechanisms]
Fl Nachon1, Y Nicolet, P Masson
1Centre de Recherche du Service de Santé des Armées, Département de toxicologie, Unité d'enzymologie, BP 87, F38702 La Tronche Cedex. fnachon@crssa.net
Annales Pharmaceutiques Francaises
|June 25, 2005
Summary
Organophosphorus compounds target cholinesterases, but current treatments for poisoning are imperfect. The development of catalytic bioscavengers and understanding human butyrylcholinesterase (BChE) structure offers new hope for medical countermeasures.
Area of Science:
- Biochemistry
- Pharmacology
- Toxicology
Background:
- Cholinesterases are primary targets for organophosphorus compounds.
- Despite advances, prophylaxis and treatment for nerve agent poisoning remain suboptimal.
- Classical pharmacological approaches have limited potential for significant improvement.
Purpose of the Study:
- To explore the potential of catalytic bioscavengers for organophosphorus poisoning.
- To elucidate the structure and function of human butyrylcholinesterase (BChE) for medical defense.
- To engineer improved BChE variants for detoxification.
Main Methods:
- Structural analysis of human BChE.
- Investigating cholinesterase catalytic mechanisms and inhibition.
- Studying the aging mechanism of phosphylated cholinesterases.
- Employing site-directed mutagenesis to create functional BChE mutants.
Main Results:
- The 3D structure of human BChE provided insights into catalytic mechanisms and inhibition.
- Understanding of the phosphylated cholinesterase aging process was enhanced.
- Development of strategies for engineering BChE mutants for organophosphorus detoxification.
Conclusions:
- Catalytic bioscavengers represent a promising new strategy for nerve agent countermeasures.
- Structural and mechanistic insights into BChE are crucial for developing effective medical defenses.
- Engineered BChE variants hold potential for improved detoxification of organophosphorus compounds.